← Back to Patent Explorer
US4364861A Expired / Lapsed US ⏱️ 0.0 years remaining

Blood-coagulation-promoting products and methods of preparing them

Assignee: Oesterreichisches Institut fuer Haemoderivate
•
Filing: 1980-05-27
•
Granted: 1982-12-21
•
Expires: 2000-05-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Blood-coagulation-promoting products substantially free of thrombin are prepared from human blood plasma by contacting a human blood plasma fraction containing coagulation Factors II, VII, IX and X with an anion exchanger to adsorb the coagulation Factors, which are subsequently eluted from the anion exchanger. The eluate is treated to generate a substance having Factor VIII Inhibitor Bypassing Activity and being substantially free of thrombin, and activated Factor X.

Inventors

  • 👤 Gautam Mitra
  • 👤 Michael H. Coan
  • 👤 Shohachi Wada

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:09
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/647; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83; Y10S530/831

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 68 words
A pharmaceutical preparation free of heparin, comprising coagulation Factors II, VII, IX, and X and having Factor VIII Inhibitor Bypassing Activity (FEIB-activity) wherein the FEIBA:Factor II ratio, the FEIBA:Factor VII ratio, the FEIBA:Factor IX ratio, and the FEIBA:Factor X ratio, are about 10:1 to 0.1:1, respectively, and wherein the FEIBA:activity is at least about 60 Units per milliliter and wherein the FEIBA:thrombin ratio is at least about 50:1.
Claim 2
Dependent Claim 68 words
A pharmaceutical preparation free of heparin, comprising coagulation Factors II, VII, IX, and X and having Factor VIII Inhibitor Bypassing Activity (FEIB-activity) wherein the FEIBA:Factor II ratio, the FEIBA:Factor VII ratio, the FEIBA:Factor IX ratio, and the FEIBA:Factor X ratio, are about 10:1 to 0.1:1, respectively, and wherein the FEIBA:activity is at least about 60 Units per milliliter and wherein the FEIBA:thrombin ratio is at least about 50:1.
Claim 3
Dependent Claim 15 words
The preparation of claim 1 wherein the FEIBA:Factor Xa ratio is at least about 45:1.
Claim 4
Dependent Claim 43 words
The preparation of claim 1 wherein the FEIBA:Factor II ratio is about 1.5:1 to 6:1, the FEIBA:Factor VII ratio is about 0.5:1 to 1.5:1, the FEIBA:Factor IX ratio is about 1:1 to 2:1, and the FEIBA:Factor X ratio is about 1.5:1 to 7:1.
Claim 5
Dependent Claim 16 words
The preparation of claim 1 which contains less than 1.5 Units per millilter of thrombin activity.
Claim 6
Dependent Claim 24 words
The preparation of claim 1 which contains less than 0.5 Units per milliliter of thrombin and the FEIBA:thrombin ratio is about 1000:1 or higher.
Claim 7
Dependent Claim 63 words
A pharmaceutical preparation free of detectable thrombin and heparin, comprising coagulation Factors II, VII, IX, and X and having Factor VIII Inhibitor Bypassing Activity (FEIB-activity) wherein the FEIBA:Factor II ratio is about 1.5:1 to 6:1, the FEIBA:Factor VII ratio is about 0.5:1 to 1.5:1, the FEIBA:Factor IX ratio is about 1:1 to 2:1, and the FEIBA:Factor X ratio is about 1.5:1 to 7:1.
Claim 8
Dependent Claim 63 words
A pharmaceutical preparation free of detectable thrombin and heparin, comprising coagulation Factors II, VII, IX, and X and having Factor VIII Inhibitor Bypassing Activity (FEIB-activity) wherein the FEIBA:Factor II ratio is about 1.5:1 to 6:1, the FEIBA:Factor VII ratio is about 0.5:1 to 1.5:1, the FEIBA:Factor IX ratio is about 1:1 to 2:1, and the FEIBA:Factor X ratio is about 1.5:1 to 7:1.

References Cited (Backward Citations)

US3717708A Cited
US3560475A Cited
US3682881A Cited
US4081431A Cited
US4170590A Cited
US4160025A Cited
US4272523A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-12-20 1986-06-21 1986-12-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-12-20 1990-06-21 1990-12-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-12-20 1994-06-21 1994-12-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag